Biotech Asia News

Medical Biotechnology | Antibiotics | Pharmaceutical | Vaccines | Announcements |

Speed Medical SAE, Secures EGP 1.57 Billion Capital Commitment from Global Emerging Markets (GEM)

Speed Medical Company (EGX: SPMD), today announced a EGP 1.57 billion capital commitment from GEM Global Yield LLC SCS (“GGY”), the Luxembourg based private alternative investment group.

Under the agreement, GGY will provide Speed Medical Co. (SPMD) with a Share Subscription Facility of up to EGP 1,570 million for a 36-month term to use at its discretion, subject to agreed upon terms. The company will have no minimum drawdown obligation and is authorized to utilize the facility on an as-need basis over the life of the agreement.

“We are pleased to receive what we believe is potentially lower cost and less dilutive financing, as the company controls the timing and amount of each drawdown. The new facility will provide financing that can be deployed for acquisitions, our aggressive expansion plans, new venture financing as well as consolidating current bank obligations. The facility will help the company to maintain its growth and at the same time start distributing cash dividends to its shareholders commencing in the coming year,” Chairman of SPMD, Mahmoud Lasheen, was quoted.